Concentrated biosynthesis of tobramycin by genetically engineered Streptomyces tenebrarius

The Journal of General and Applied Microbiology
Jianping XiaoWenrong Hong

Abstract

Tobramycin is an important broad spectrum aminoglycoside antibiotic widely used against severe Gram-negative bacterial infections. It is produced by base-catalyzed hydrolysis of carbamoyltobramycin (CTB) generated by S. tenebrarius. We herein report the construction of a genetically engineered S. tenebrarius for direct fermentative production of tobramycin by disruption of aprK and tobZ. A unique putative NDP-octodiose synthase gene aprK was disrupted to optimize the production of CTB, resulting in the blocking of apramycin biosynthesis and the obvious increase in CTB production of aprK disruption mutant S. tenebrarius ST316. Additional mutation on the carbamoyltransferase gene tobZ in S. tenebrarius ST316 generated a strain ST318 that produces tobramycin as a single metabolite. ST318 could be used for industrial fermentative production of tobramycin.

References

Dec 8, 2004·Bioorganic & Medicinal Chemistry Letters·Madan K KharelJae Kyung Sohng
May 5, 2005·Applied and Environmental Microbiology·Irina BorodinaJens Nielsen
Apr 14, 2009·Methods in Enzymology·Fumitaka Kudo, Tadashi Eguchi
Aug 1, 2009·The Journal of Antibiotics·Fumitaka Kudo, Tadashi Eguchi
Oct 12, 2010·Applied Microbiology and Biotechnology·Xianpu NiHuanzhang Xia
Oct 11, 2011·Nature Chemical Biology·Je Won ParkYeo Joon Yoon
Apr 2, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Nicola AltamuraMonica Borgatti

❮ Previous
Next ❯

Citations

Jul 25, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lena MitousisEwa M Musiol-Kroll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.